Some older adults with diabetes overtreated for their disease
the ONA take:
According to a new study published in JAMA Internal Medicine, many older adults with diabetes are being overtreated for their disease.
For the study, researchers from Yale University School of Medicine in New Haven, Connecticut, identified nearly 1,300 adults aged 65 years and older with diabetes from the National Health and Nutrition Examination Survey (NHANES) and separated them into three cohorts depending on their state of health: relatively healthy, complex/intermediate health, and very complex/poor health.
Results showed that among all participants, 61.5% had tight glycemic control, which was defined as an A1C less than 7%. In the relatively healthy group, 62.8% had tight glycemic control compared with 63% of those in the complex/intermediate health group and 56.4% of those in the very complex/poor health group.
In addition, about 55% of patients were treated with either sulfonylureas or insulin. Although the American Diabetes Association recommends an A1C level less than 7% among patients with diabetes, older patients are more susceptible to hypoglycemia and may benefit less from such tight glycemic control.
Those with diabetes in complex/intermediate or very complex/poor health are at a higher risk of treatment-related harms and less likely to derive benefit from intensive glycemic control.
Many older adults with diabetes are being overtreated for their disease.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|